desmopressin acetate
NDC 25021-460, desmopressin acetate, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-460
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204695
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-460 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESMOPRESSIN ACETATE4 ug/mL
Pharmacologic classes
Factor VIII Activator [EPC]; Increased Coagulation Factor VIII Activity [PE]; Increased Coagulation Factor VIII Concentration [PE]; Vasopressin Analog [EPC]; Vasopressins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-460-01 | 25021046001 | 10 VIAL in 1 CARTON (25021-460-01) / 1 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/39381e84-0e87-4731-b725-f0fdf4b5ca2bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-460NADAC price for package 25021046001
GET /v1/drugs/nadac/25021046001
Use it
Look up 25021-460 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-460 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-460. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.